CERAMENT® G | Overview

CERAMENT® G Clinical Evidence

The CERAMENT^® G platform has been studied for more than 10 years and is supported by over 240+ publications and abstracts, including a Level 1 Randomized Control Trial (RCT) and a Long-Term Study.

94% success in eradication of infection¹

Graphic: CERAMENT used in 70,000+ Patients, Over 240 Publications and Abstracts

CLINICAL STUDY & PATIENT RESULTS

Graphic Ring: 94% Infection Free after 6 Years

INFECTION-FREE
AFTER 6 YEARS¹

Graphic Ring: 66% Reduction in Readmissions

REDUCTION IN
READMISSIONS²

Graphic Ring: 40% Reduction in Length of Stay

REDUCTION IN
LENGTH OF STAY³

Explore Evidence by Indication or Attribute

Chronic Osteomyelitis

Antibiotic Elution

Fracture Related Infection

Bone Remodeling

Diabetic Foot Infection

Health Economics

McNally et al. Mid- to long-term results of single-stage surgery for patients with chronic osteomyelitis using a bioabsorbable gentamicin-loaded ceramic carrier.
Bone Joint J. 2022 Sep;104-B(9):1095-1100. doi: 10.1302/0301-620X.104B9.BJJ-2022-0396.R1. PMID: 36047024; PMCID: PMC9948464.
Ferguson et al. “A retrospective cohort study comparing clinical outcomes and healthcare resource utilisation in patients undergoing surgery for osteomyelitis in England:
a case for reorganising orthopaedic infection services.” Journal of bone and joint infection vol. 6,5 151-163. 28 Apr. 2021.

CERAMENT® G Clinical Evidence

CLINICAL STUDY & PATIENT RESULTS

INFECTION-FREE AFTER 6 YEARS1

REDUCTION IN READMISSIONS2

REDUCTION IN LENGTH OF STAY3

Explore Evidence by Indication or Attribute

INFECTION-FREE
AFTER 6 YEARS¹

REDUCTION IN
READMISSIONS²

REDUCTION IN
LENGTH OF STAY³